More strikingly, the expression of KLF9 was further downregulated in the patients who developed intrahepatic metastasis at diagnosis compared to patients who did not have metastatic diseases (Figure 6C), further suggesting an antimetastasis role of KLF9 in liver cancer. This evidence concerns the gene KLF9 and liver cancer.